Nicox's $120M Aciex deal gives CRO Ora a bigger partner

Ophthalmic CRO Ora is inheriting a relationship with drugmaker Nicox after the French outfit agreed to buy Aciex Therapeutics, a Boston-based biotech at work on eye treatments. Under a longstanding relationship, Aciex and Ora developed a pipeline of treatments for ocular allergy, dry eye and other inflammatory conditions, and Nicox said it intends to keep the partnership in place when its cash and stock deal closes. News

Suggested Articles

The platform uses wearables to continuously collect clinical data from study participants and applies machine learning to analyze the data.

Analytica Laser has a novel system which the company touts as the industry's first dynamic tool to predict real-world health outcomes.

Genae's CEO says the transaction reflects recent focus on digital health and data-driven services.